Berberine attenuates septic cardiomyopathy by inhibiting TLR4/NF-κB signalling in rats
Context Berberine (Ber) can increase the survival rate of septic mice and inhibit inflammation, but whether it has a protective effect on septic cardiomyopathy (SCM) is unclear. Objective To investigate whether Ber ameliorates SCM in a rat model and its potential mechanism. Materials and methods Mal...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2021-01-01
|
| Series: | Pharmaceutical Biology |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/13880209.2021.1877736 |